Roche Diagnostics cobas® pro i 601 analyzer - HSA Registration DE0510492
Access comprehensive regulatory information for Roche Diagnostics cobas® pro i 601 analyzer in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0510492 and owned by Roche Diagnostics GmbH. The device was registered on March 24, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The cobas pro i 601 analyzer is an integrated fully automated, random-access, software controlled clinical analyzer for bead-based, liquid chromatography, sample preparation and mass spectrometry analysis for quantitative in-vitro determinations. The cobas i601 analyzer is intended to identify naturally occurring and synthetic compounds (e.g., steroids, vitamins, opiates, benzodiazepines and others) in human specimens by ionizing the compound under investigation and separating the resulting ions by means of an electrical and magnetic field according to their mass-to-charge ratio.